Brief: Dormakaba H1 Organic Sales Growth Of 3.9%

Dormakaba Holding AG

05/03/2024 05:33

March 5 (Reuters) - DORMAKABA HOLDING AG  DOKA.S :
    * FIRST HALF OF THE FINANCIAL YEAR 2023/24: DORMAKABA
REPORTS
ORGANIC GROWTH OF 3.9% AND SIGNIFICANT MARGIN IMPROVEMENT
    * OUTLOOK FOR FULL FINANCIAL YEAR 2023/24 UNCHANGED
    * H1 ORGANIC SALES GROWTH OF 3.9% (OF WHICH 3.1% RELATES TO
PRICING)
    * H1 CASH GENERATED FROM OPERATIONS INCREASED DUE TO
IMPROVEMENTS
IN NET WORKING CAPITAL TO CHF 146.0 MILLION (PREVIOUS YEAR CHF
137.6 MILLION)
    * H1 NET PROFIT OF CHF 48.5 MILLION (PREVIOUS YEAR: CHF 54.3
MILLION)
    * H1 ADJUSTED EBITDA INCREASED BY 8.7% TO CHF 200.7 MILLION
(PREVIOUS YEAR: CHF 184.6 MILLION), WITH AN ADJUSTED EBITDA
MARGIN OF 14.6% (PREVIOUS YEAR: 13.0%)
    * H1 NET SALES OF CHF 1,376.5 MILLION (PREVIOUS YEAR: CHF
1,419.8
MILLION)
    * NET FINANCIAL DEBT DECREASED BY CHF 150.2 MILLION TO CHF
586.5
MILLION AS OF 31 DECEMBER 2023 (PREVIOUS YEAR: CHF 736.7
MILLION)

Source text for Eikon:  ID:nEQ1VH8B1a 
Further company coverage:  DOKA.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))